A €10,000 Award supported by Actelion Pharmaceuticals Ltd will be awarded for the best advance and research in pulmonary arterial hypertension (PAH) from a young investigator aged under 40 years.
Application must be made via the electronic abstract submission form.
Abstract submission deadline was February 21, 2008. Notification of selection will be sent in May 2008.
